Sven Arne Silfverdal

Prof. Sven Arne Silfverdal

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2003 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
LHLars Å. Hanson
Lars Å. Hanson
MKMarina Korotkova
Marina Korotkova
SLSamuel Lundin
Samuel Lundin
LHLiljana Håversen
Liljana Håversen
SSSven Arne Silfverdal
Sven Arne Silfverdal
ETEsbjörn Telemo
Esbjörn Telemo

13 December 2013 in Epidemiology and Infection
Verified
Journal Article
Open access
JLJ. G. Liese
J. G. Liese
SSSven Arne Silfverdal
Sven Arne Silfverdal
CGC. Giaquinto
C. Giaquinto
ACA. Carmona
A. Carmona
JLJ. H. Larcombe
J. H. Larcombe
MRM. R. Rosenlund
M. R. Rosenlund
SUMMARY: We conducted an epidemiological, observational cohort study to determine the incidence and complications of acute otitis media (AOM) in children aged <6 years. Data on physician-diagnosed AOM were collected from retrospective review of medical charts for the year preceding enrolment and then prospectively in the year following enrolment. The study included 5776 children in Germany, Italy, Spain, Sweden, and the UK. AOM incidence was 256/1000 person-years [95% confidence interval (CI) 243–270] in the prospective study period. Incidence was lowest in Italy (195, 95% CI 171–222) and highest in Spain (328, 95% CI 296–363). Complications were documented in <1% of episodes. Spontaneous tympanic membrane perforation was documented in 7% of episodes. Both retrospective and prospective study results were similar and show the high incidence during childhood in these five European countries. Differences by country may reflect true differences and differences in social structure and diagnostic procedures.

16 January 2020 in Molecular Autism
Verified
Journal Article
Open access
PDF file
OEOlga Egorova
Olga Egorova
RMRobin Myte
Robin Myte
JSJörn Schneede
Jörn Schneede
BHBruno Hägglöf
Bruno Hägglöf
Sven BölteSven Bölte
Sven Bölte
SSSven Arne Silfverdal
Sven Arne Silfverdal
Background: Autism spectrum disorder (ASD) evolves from an interplay between genetic and environmental factors during prenatal development. Since identifying maternal biomarkers associated with ASD risk in offspring during early pregnancy might result in new strategies for intervention, we investigated maternal metabolic biomarkers in relation to occurrence of ASD in offspring using both univariate logistic regression and multivariate network analysis.Methods: Serum samples from 100 women with an offspring diagnosed with ASD and 100 matched control women with typically developing offspring were collected at week 14 of pregnancy. Concentrations of 62 metabolic biomarkers were determined, including amino acids, vitamins (A, B, D, E, and K), and biomarkers related to folate (vitamin B9) metabolism, lifestyle factors, as well as C-reactive protein (CRP), the kynurenine-tryptophan ratio (KTR), and neopterin as markers of inflammation and immune activation.Results: We found weak evidence for a positive association between higher maternal serum concentrations of folate and increased occurrence of ASD (OR per 1 SD increase: 1.70, 95% CI 1.22–2.37, FDR adjustedP= 0.07). Multivariate network analysis confirmed expected internal biochemical relations between the biomarkers. Neither inflammation markers nor vitamin D3levels, all hypothesized to be involved in ASD etiology, displayed associations with ASD occurrence in the offspring.Conclusions: Our findings suggest that high maternal serum folate status during early pregnancy may be associated with the occurrence of ASD in offspring. No inference about physiological mechanisms behind this observation can be made at the present time because blood folate levels may have complex relations with nutritional intake, the cellular folate status and status of other B-vitamins. Therefore, further investigations, which may clarify the potential role and mechanisms of maternal blood folate status in ASD risk and the interplay with other potential risk factors, in larger materials are warranted.

22 January 2020 in Acta Paediatrica
Verified
Journal Article
Open access
PDF file
ARAntonia Reuter
Antonia Reuter
SSSven Arne Silfverdal
Sven Arne Silfverdal
KLKristin Lindblom
Kristin Lindblom
AHAnders Hjern
Anders Hjern
Aim: The aim of this review was to evaluate the evidence for interventions for behavioural sleep problem in infants.Methods: Systematic review based on a search in MEDLINE, Web of Science and PsychINFO in December 2017 for articles published in English during 2007‐2017 about preventive and treatment interventions for sleep problems in infants. The review included controlled trials and meta‐analyses with at least 20 infants in study groups assessed according to the Grading of Recommendations Assessment, Development and Evaluation criteria.Results: Out of 476 original articles assessed for eligibility, 12 studies were included in the synthesis. Interventions with behavioural, educational and massage strategies were evaluated. No intervention was evaluated in more than one trial. Five interventions with behavioural methods for establishing consistent routines or controlled crying showed modest short‐term effects, while the evidence for elements of education was inconsistent. Studies of massage were of poor quality. Knowledge gaps were identified regarding interventions in cross‐cultural context, involving fathers, in children below six months of age, in high‐risk populations and consequences of interventions that include extinction.Conclusion: Some support for short‐term effects of behavioural treatment strategies was found, but more studies are needed to establish evidence.

1 April 1997 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
SSSven Arne Silfverdal
Sven Arne Silfverdal
LBL Bodin
L Bodin
SHS Hugosson
S Hugosson
OGO Garpenholt
O Garpenholt
BWB Werner
B Werner
POP Olcen
P Olcen
BACKGROUND: In Orebro County a 2.5-fold increase in the incidence of Haemophilus influenzae (HI) meningitis was found between 1970 and 1980, an observation that initiated the present study. MATERIALS AND METHODS: In order to search for associations between morbidity in invasive HI infection and possible risk factors, a case-control study was conducted over a 6-year period from 1987 to 1992, before general Hib vaccination was introduced in Sweden. Fifty-four cases with invasive HI infection 139 matched controls were studied for possible risk factors such as day-care outside the home, short duration of breastfeeding, passive smoking, low socioeconomic level of the household, many siblings in the family, allergy, frequent, infections, repeated antibiotic treatments and immunoglobulin deficiency. RESULTS: Multivariate analysis showed a significant association between invasive HI infection and two independent factors, i.e. short duration (< 13 weeks) of exclusive breastfeeding, odds ratio (OR) 3.79 (95% confidence interval [CI] 1.6-8.8) and history of frequent infections, OR 4.49 (95% CI : 1.0-21.0). For the age at onset 12 months or older, the associations were stronger, OR 7.79 (95% CI : 2.4-26.6) and 5.86 (95% CI : 1.1-30.6), respectively. When breastfeeding duration in weeks was analysed as a continuous variable the OR was 0.95 (95% CI : 0.92-0.99), indicating a decreased risk with each additional week. Increased OR were observed for other risk factors as well but not of the magnitude found for short duration of breastfeeding. DISCUSSION: The association of decreased risk for invasive HI infection and long duration of breastfeeding was persisting beyond the period of breastfeeding itself. This finding supports the hypothesis of a long-lasting protective effect of breastfeeding on the risk for invasive HI infection. CONCLUSION: A decreased risk for invasive HI infection with long duration of breastfeeding was found. Our results do have implications for strategies in breastfeeding promotion, especially in countries where Hib vaccination is too costly and not yet implemented.

1 October 2009 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
SSSven Arne Silfverdal
Sven Arne Silfverdal
BHBirthe Hogh
Birthe Hogh
MBMarianne Riise Bergsaker
Marianne Riise Bergsaker
HSHelena Skerlikova
Helena Skerlikova
PLPatricia Lommel
Patricia Lommel
LSLode Schuerman
Lode Schuerman
The immunogenicity of the 10-valent pneumococcal nontypeable Haemophilusinfluenzae protein D-conjugate vaccine (PHiD-CV) was determined following a simplified 2-dose priming and the more commonly employed 3-dose priming both followed by a booster dose. A total of 351 healthy subjects were primed with PHiD-CV at either 3 and 5 or 3, 4 and 5 months of age followed in all subjects by a booster dose at 11 to 12 months of age. Serotype-specific pneumococcal responses were measured by 22F-inhibition ELISA and opsonophagocytic assays 1 month following primary and booster vaccinations. Depending on the serotype, the percentages of subjects reaching the ELISA antibody threshold of 0.2 μg/mL were 92.8% to 98.0% following 2 primary doses and 96.1% to 100% following 3 primary doses except for serotype 6B (55.7% and 63.1%, respectively) and serotype 23F (69.3% and 77.6%, respectively). Opsonophagocytic activity (OPA) could be measured in 74.4% to 100% and 88.9% to 100% of the subjects after the 2-dose or 3-dose priming, respectively, except for serotype 1 (60.8% and 62.9%, respectively). In both groups, robust increases in ELISA antibodies and OPA titers were observed for all serotypes after the booster dose. Higher postprimary and postbooster ELISA antibody levels and OPA titers were observed for most serotypes following the 3+1 schedule. PHiD-CV was immunogenic in both schedules, but further effectiveness data are needed to fully understand the public health benefit to be expected from these schedules in terms of prevention against invasive and mucosal infections.